Liversedge L A, Yuill G M, Wilkinson I M, Hughes J A
J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):412-5. doi: 10.1136/jnnp.37.4.412.
Twenty-one of 29 patients suffering from myasthenia gravis derived benefit from a short intensive course of adrenocorticotrophin (ACTH). The mean duration of benefit was approximately six months. The best results were obtained in patients with a short history of myasthenia. Transient deterioration during the course of injections was encountered in some cases but necessitated assisted respiration only in patients with severe generalized weakness before treatment.
29例重症肌无力患者中有21例从短期强化促肾上腺皮质激素（ACTH）治疗中获益。获益的平均持续时间约为6个月。重症肌无力病史较短的患者取得了最佳疗效。部分病例在注射过程中出现短暂病情恶化，但仅在治疗前有严重全身无力的患者中需要辅助呼吸。
